$25.16 0.39 (+1.57%)
12/3/2009 4:04 PM

Bristol-Myers Squibb Co. (BMY)

CAPS Rating: 4 out of 5

The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.

Recs

6
Member Avatar BringUs (86.02) Submitted: 5/4/2009 12:43:43 PM : Outperform Start Price: $19.00 BMY Score: +8.14

The insiders are buying. The dividend is fat. They haven't eaten up another company like their bio/pharma bretheren (think PFE, MRK, Roche), so they don't have any rocky integrations to worry about. They have a stocked pipeline ( http://www.bms.com/research/pipeline/Pages/default.aspx).
Plus, we have a 1995 sale price. If you ever wanted to go back in time, well...

Report this Post 0 Comments

Featured Broker Partners